Targeting FDA user fees would leave agency gutted, experts say
Dr. Marty Makary, nominee to be commissioner of the FDA, appears before the Senate Health, Education, Labor and Pensions Committee for his confirmation hearing in the Dirksen Senate Office Building in Washington on March 6.